These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15377178)

  • 1. Detection of anti-D following antepartum injections of Rh immune globulin.
    Kennedy MS; McNanie J; Waheed A
    Immunohematology; 1998; 14(4):138-40. PubMed ID: 15377178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets.
    Ewing CA; Rumsey DH; Langberg AF; Sandler SG
    Immunohematology; 1998; 14(4):133-7. PubMed ID: 15377177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.
    Welsh KJ; Bai Y;
    Am J Clin Pathol; 2016 Jun; 145(6):744-51. PubMed ID: 27267375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Rh immune globulin prevents alloimmunization in D- granulocyte recipients but obscures the detection of an allo-anti-K.
    Stroncek DF; Procter JL; Moses L; Bolan C; Pomper GJ; Conroy-Cantilena C; Malech HL; Klein HG; Leitman SF
    Immunohematology; 2001; 17(2):37-41. PubMed ID: 15373589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and Follow-up of Massive Fetomaternal Hemorrhage Requiring High-Dose Rh Immune Globulin: A Case Report.
    Fortes PA; Gnass ED; Baez J; Bayati B; Mei Z; McGonigle AM; Ziman A; Ward DC
    Am J Clin Pathol; 2023 Jul; 160(1):78-80. PubMed ID: 36897771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2.
    Branch DR; Shabani F; Lund N; Denomme GA
    Transfusion; 2006 Aug; 46(8):1316-22. PubMed ID: 16934066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postinjection kinetics of antepartum Rh immune globulin.
    Witter FR; Shirey RS; Nicol SL; Ness PM
    Am J Obstet Gynecol; 1990 Sep; 163(3):784-6. PubMed ID: 2169705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rh immune globulin: an interfering substance in compatibility testing.
    Casina TS; Sandler SG; Autenrieth SM
    Immunohematology; 2019 Jun; 35(2):51-60. PubMed ID: 31246488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory management of perinatal patients with apparently "new" anti-D.
    Hannon JL; Clarke G
    Immunohematology; 2016 Sep; 32(3):108-111. PubMed ID: 27834484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic aspects of treating immune thrombocytopenic purpura using intravenous Rh immune globulin.
    Savasman CM; Sandler SG
    Immunohematology; 2001; 17(4):106-10. PubMed ID: 15373575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin.
    Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW
    Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and benefits of non-invasive fetal RhD determination.
    Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of anti-D in women at birth following antepartum immune globulin prophylaxis.
    Rudensky B; Mazaki E; Na'amad M; Samueloff A
    Eur J Obstet Gynecol Reprod Biol; 2003 Mar; 107(1):45-6. PubMed ID: 12593893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Rh immune globulin suppress HLA sensitization in pregnancy?
    Kaufman RM; Schlumpf KS; Wright DJ; Triulzi DJ;
    Transfusion; 2013 Sep; 53(9):2069-77. PubMed ID: 23252646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.
    Branch DR; Scofield TL; Moulds JJ; Swanson JL
    Transfusion; 2011 Apr; 51(4):816-9. PubMed ID: 20946183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of different testing methods for identification of RhIG in red blood cell antibody detection.
    Mikesell KV; George MR; Castellani WJ; Domen RE; Gould JM; Davis JW; Herman JH
    Transfusion; 2015 Jun; 55(6 Pt 2):1444-50. PubMed ID: 25648788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated anti-D titer after the administration of Rh immune globulin. A case report.
    Andres RL; Branch DW; Scott JR
    J Reprod Med; 1989 Apr; 34(4):318-20. PubMed ID: 2497253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.